A Panel of Human Monoclonal Antibodies for Tracking the Antigenic Evolution of Influenza H5N1 Clade 2.3.4.4b
Hong, H.; Morano, N. C.; Wu, M.; Chong, S.; Yu, J.; Huang, Y.; Nair, M. S.; Li, Z.; Tzang, C.-C.; Becker, J. E.; Wang, C.; Shapiro, L.; Kwong, P. D.; Guo, Y.; Ho, D. D.
Show abstract
The ongoing panzootic of clade 2.3.4.4b H5N1 influenza has resulted in widespread infection of birds, mammals, and livestock, underscoring the need for tools to interpret its real-time evolution. Here, we describe the isolation and characterization of a panel of 19 human monoclonal antibodies that potently neutralize current isolates. Competition immunoassays and cryo-electron microscopy analyses revealed their collective near-complete epitope coverage of the H5-hemagglutinin surface. Neutralization profiling across multiple historical and contemporary H5 viruses defined their epitope-specific patterns of virus neutralization. One cluster of antibodies potently neutralized only clade 2.3.4.4b viruses, while many others exhibited broadly neutralizing activity against diverse H5N1 clades. Application of this structurally calibrated antibody panel to recent North American human isolates revealed genotype-specific antigenic divergence between lineages that have spread among cattle (B3.13) and poultry (D1.1). Together, the findings of this study establish a structurally grounded antibody reference panel spanning major vulnerable sites of H5 hemagglutinin and provide a toolbox for interpreting emergent mutations, monitoring ongoing antigenic drift, and anticipating the evolutionary trajectory of circulating H5N1 influenza viruses.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Optimizing a Human Monoclonal Antibody for Better Neutralization of SARS-CoV-2 98%
- Structural basis of broad protection against influenza virus by a human antibody targeting the neuraminidase active site via a recurring motif in CDR H3 98%
- A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo 97%
Similar papers in this journal
- Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity in uninfected and previously infected individuals 98%
- Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals 97%
- SARS-CoV-2 B.1.1.7 escape from mRNA vaccine-elicited neutralizing antibodies 97%
Similar papers in this journal
- Viral evolution prediction identifies broadly neutralizing antibodies against existing and prospective SARS-CoV-2 variants 98%
- Spatial, Quantitative and Functional Deconstruction of Virus and Host Protein Interactions Inside Intact Cytomegalovirus Particles 96%
- Dipeptidase 1 is a functional receptor for coronavirus PHEV 96%
Similar papers in this journal
- Broadly neutralizing antibodies target the coronavirus fusion peptide 96%
- Rapid isolation of potent SARS-CoV-2 neutralizing antibodies and protection in a small animal model 96%
- Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.